These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6290705)

  • 1. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activities of cefotiam against various pathogens isolated from clinical materials (author's transl)].
    Murase M; Niiya T; Katayama Y; Takeuchi N
    Jpn J Antibiot; 1982 Apr; 35(4):1004-8. PubMed ID: 6285018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with cefotiam in otorhinolaryngologic infections].
    Yajin K; Harada Y; Takeuchi M; Chikuya D; Noda M; Hirata K
    Jpn J Antibiot; 1983 Oct; 36(10):2721-9. PubMed ID: 6325742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies of cefotiam in the field of otorhinolaryngology].
    Takeda K; Yoshida M; Ishida T
    Jpn J Antibiot; 1983 Oct; 36(10):2715-20. PubMed ID: 6325741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of cefotiam in otorhinolaryngologic infections].
    Sato F; Tachibana M; Saito H; Mizukoshi O; Nishimura T; Saito A; Nakamura A; Okawa K; Takenouchi S; Yanohara K
    Jpn J Antibiot; 1983 Oct; 36(10):2688-92. PubMed ID: 6325738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
    van Asbeck BS; Marcelis JH; van Kats JH; Jaarsma EY; Verhoef J
    Eur J Clin Microbiol; 1983 Oct; 2(5):432-8. PubMed ID: 6315421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
    Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
    Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of cefotiam in otorhinolaryngologic infections].
    Satake K; Tanino T; Naito T; Osafune H; Komatsuzaki A
    Jpn J Antibiot; 1983 Oct; 36(10):2683-7. PubMed ID: 6325737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial activity of cefotiam against various clinical isolates from 1981 to 1985].
    Matsuo K; Uete T
    Jpn J Antibiot; 1986 Aug; 39(8):1981-7. PubMed ID: 3467078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide surveillance of 6 otorhinolaryngological infectious diseases and antimicrobial susceptibility pattern in the isolated pathogens in Japan.
    Suzuki K; Kurono Y; Ikeda K; Watanabe A; Iwamoto A; Totsuka K; Kaku M; Iwata S; Kadota J; Hanaki H
    J Infect Chemother; 2015 Jul; 21(7):483-91. PubMed ID: 26004175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity of cefotiam against clinical isolates in the field of obstetrics and gynecology].
    Deguchi K
    Jpn J Antibiot; 1983 Apr; 36(4):678-88. PubMed ID: 6308295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance spectrum of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H; Wagner J
    Immun Infekt; 1983 Jun; 11(4):140-2. PubMed ID: 6099820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs].
    Uete T; Tsuzaki Y; Furukawa S; Matsuo K
    Jpn J Antibiot; 1982 Jun; 35(6):1441-61. PubMed ID: 6290707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.